Wikidata

(Q90693693)

English

Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 (2020-04-30)

clinical trial

In more languages

Statements

short name
APN01-COVID-19 (English)
0 references
title
Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 (English)
0 references
country
Austria
0 references
Denmark
0 references
Germany
0 references
start time
April 2020
0 references
end time
September 2020
0 references
number of participants
200
0 references
minimum age
35 year
0 references
maximum age
80 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q90693693&oldid=1859178439"